The Unique Device Identification (UDI) system was created to give regulators, clinicians, and patients a clear, standardized way to identify medical devices across their entire lifecycle. At the center of this system is the Global Unique Device Identification Database (GUDID), the FDA-managed repository that houses key device identification data for nearly every medical device sold in the United States.
Accurate and timely GUDID submissions are essential for maintaining FDA market authorization, supporting supply-chain traceability, improving post-market surveillance, and ensuring patient safety. For manufacturers and labelers, compliance isn’t just a one-time data upload, it requires ongoing maintenance, periodic reviews, and robust internal processes to keep records up to date.
What Is GUDID?
GUDID (Global Unique Device Identification Database) is the FDA’s central repository for device identification (DI) and certain production information (PI). If someone searches “what is GUDID?” or “FDA UDI database,” this is the definition they expect to see in the first few lines and it’s exactly how the FDA describes it.
Every device that requires a UDI label must have a corresponding DI record in GUDID. This data becomes publicly accessible through AccessGUDID, allowing the healthcare ecosystem to verify device identifiers, packaging information, MRI safety status, and more.
In short:
GUDID = the authoritative source for FDA-regulated UDI data.
Who Must Submit Data to GUDID?
GUDID submission responsibilities fall primarily on the labeler, which is typically the manufacturer but may also include specification developers, repackagers, or relabelers. Any device that requires UDI labeling generally requires a GUDID record.
This includes:
- Class II and Class III devices
- Most Class I devices (unless exempt)
- Reprocessed single-use devices
- Convenience kits (with some nuanced exemptions)
There are also scenarios where exemptions or alternative pathways apply, such as private-label arrangements or certain legacy devices. Understanding who is required to submit to GUDID depends on device class, regulatory status, and how the product is marketed.
What Information Must Be Submitted to GUDID?
To support traceability and post-market safety, GUDID requires structured, standardized information about each device. While the Device Identifier is always the core data point, numerous additional attributes must be included.
Key fields include:
- Device Identifier (DI)
- Device description
- MRI safety information
- Sterilization status
- Packaging hierarchy details
- Storage and handling requirements
- Direct marking requirements (when applicable)
- Catalog number, model number, and version
- Company and labeling information
How to Submit Data to GUDID
Manufacturers can choose from three primary submission pathways depending on volume, resources, and internal systems.
Submission Methods
- GUDID Web Interface: Best for low-volume submissions or smaller portfolios. Allows manual entry and review.
- HL7 SPL Submission: Used by companies with large product portfolios and dedicated regulatory IT infrastructure.
- Third-Party RIMS/RIDM Platforms: Ideal for organizations needing automation, validation checks, and bulk upload functionality.
Step-by-Step Submission Overview
Regardless of method, the core submission process follows a similar workflow:
- Obtain or verify your DUNS number
Your DUNS number is required for GUDID account creation and serves as the official company identifier. - Request access to GUDID
This includes establishing a GUDID account and assigning user roles. - Assign UDIs to each device
Using an FDA-accredited issuing agency (GS1, HIBCC, or ICCBBA). - Prepare the DI record
This includes all required device information, packaging data, and attributes. - Upload the DI into GUDID
Via Web UI, HL7 SPL, or an integrated RIMS platform. - Validate and correct errors
GUDID will flag data inconsistencies, missing attributes, or formatting issues. - Finalize the submission
Only after the DI record is accepted does it become part of the public AccessGUDID.
This stepwise framing aligns with how users commonly search: “how to submit to GUDID,” “GUDID submission steps,”and “GUDID HL7 SPL.”
Common Submission Errors and How to Avoid Them
Here are the most frequent GUDID errors and how to prevent them:
- Incorrect DI formatting
Fix: Validate DI structure against issuing agency specifications before submission. - Missing MRI safety data
Fix: Ensure MRI compatibility fields are populated even if the device is non-MRI safe. - Incorrect packaging hierarchy
Fix: Carefully verify unit of use, base package, and higher-level packaging UDI assignments. - Inconsistent device descriptions
Fix: Use a standardized description format across the product line. - Failure to update discontinued devices
Fix: Implement internal triggers for change management and device lifecycle events.
Avoiding these errors reduces back-and-forth with regulators and helps ensure fast acceptance into the FDA UDI database.
GUDID Maintenance Requirements
GUDID compliance does not end once a device is listed. The FDA expects manufacturers to keep information accurate throughout the product lifecycle.
Manufacturers must:
- Update DI records when significant changes occur (e.g., labeling, packaging, sterilization)
- Mark records as discontinued when devices are no longer marketed
- Perform regular internal audits or annual reviews
- Validate data against production and quality systems
Search queries such as “how to update GUDID records” or “GUDID maintenance requirements” reflect a growing need for clarity on these obligations, especially as product portfolios expand.
How Regulatory Intelligence and Automation Streamline GUDID Compliance
Without automation, managing UDI data across global markets can become a resource-intensive, error-prone process. Modern regulatory intelligence platforms provide significant efficiency gains.
Capabilities include:
- Auto-population of recurring data fields
- Bulk uploads for large portfolios
- Automated validation rules to flag missing or inconsistent fields
- Change tracking and notification alerts
- Integration with global UDI systems (EUDAMED, China UDI, Korea MFDS)
These capabilities help reduce manual errors, speed up submissions, and strengthen global UDI alignment, an increasingly important priority for multinational device companies.
Global Context: How GUDID Relates to Other UDI Databases
Although GUDID is unique to the United States, many markets now require similar UDI submissions. Understanding these relationships helps manufacturers streamline global compliance.
Examples include:
- EUDAMED UDI/Device modules (EU)
- China NMPA UDI platform
- South Korea MFDS UDI database
- Saudi Arabia’s tracking system (in development)
While all systems share common principles (traceability, supply-chain transparency, patient safety) each requires different data formats, timelines, and submission processes. Queries such as “GUDID vs EUDAMED” highlight the importance of clear global comparisons.
GUDID FAQs
What is GUDID used for?
To store FDA-regulated UDI data and enable public access through AccessGUDID.
Who needs a UDI?
Most Class II and III devices and many Class I devices.
How long does submission take?
Complex portfolios may take weeks or months; individual DI entries can be processed more quickly.
What format is required for uploads?
Web UI or HL7 Structured Product Labeling (SPL).
Is Class I required to submit to GUDID?
Generally yes, unless the device is exempt.
How often must GUDID records be updated?
Whenever device attributes change or when products are discontinued.
Conclusion
GUDID is a foundational component of the FDA’s UDI framework, and compliance is essential for ensuring accurate device identification, preventing supply-chain issues, and supporting post-market safety initiatives. Maintaining high-quality, up-to-date GUDID data not only strengthens regulatory compliance, it also reduces audit risk, facilitates global market alignment, and supports better patient outcomes.
